輸入代號或公司名稱後按 Enter
1731

美吾華

0.00 (0.00%)最後更新 2026-09-16
台灣 · 上市 · 生技醫療業
20.7573成交張數13.74本益比1.26股價淨值比5.88%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20251,584年增 +6.6%
毛利率202563.2%最新一期
營業利益率202513.7%最新一期
每股盈餘20251.36年增 +4.6%
會計項目走勢2016201720182019202020212022202320242025
銷貨收入101.1%100.9%101.2%101.7%101.0%100.0%100.0%100.0%100.0%100.0%
銷貨收入淨額100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
銷貨成本57.0%57.0%42.6%39.1%36.5%33.3%34.3%35.3%36.8%
營業成本合計57.0%57.0%42.6%39.1%36.5%33.3%34.4%34.3%35.3%36.8%
營業毛利(毛損)43.0%43.0%57.4%60.9%63.5%66.7%65.6%65.7%64.7%63.2%
營業毛利(毛損)淨額43.0%43.0%57.4%60.9%63.5%66.7%65.6%65.7%64.7%63.2%
推銷費用26.0%25.5%35.3%37.3%37.7%42.0%41.7%42.7%42.9%42.5%
管理費用8.1%7.4%9.8%9.6%9.7%7.9%7.9%8.0%7.9%6.9%
預期信用減損損失(利益)-0.0%-0.1%0.1%0.0%0.0%
營業費用合計34.1%32.9%45.1%46.9%47.5%49.8%49.6%50.7%50.8%49.5%
其他收益及費損淨額-0.0%0.0%0.0%-0.5%-0.0%-1.4%0.0%-0.0%0.0%
營業利益(損失)8.8%10.1%12.2%13.4%16.0%15.5%16.0%15.0%13.9%13.7%
利息收入0.5%0.4%0.4%0.6%0.6%0.5%
其他收入1.0%0.7%1.6%2.7%2.2%2.5%1.8%1.5%1.5%1.7%
其他利益及損失淨額0.7%-0.5%0.0%0.1%3.3%0.1%0.1%0.1%0.1%0.1%
財務成本淨額0.3%0.3%0.4%0.5%0.5%0.4%0.2%0.0%0.2%0.5%
採用權益法認列之關聯企業及合資損益之份額淨額-2.8%-2.7%-3.5%-3.5%-2.0%-1.6%-1.4%-0.9%-1.2%-1.0%
營業外收入及支出合計-1.4%-2.8%-2.3%-1.2%3.5%0.9%0.7%1.2%0.7%0.7%
稅前淨利(淨損)7.4%7.3%9.9%12.2%19.5%16.4%16.7%16.2%14.7%14.4%
所得稅費用(利益)合計1.2%1.8%3.2%3.1%3.4%3.7%3.7%3.2%3.0%3.0%
繼續營業單位本期淨利(淨損)6.3%5.5%6.7%9.1%16.1%12.7%13.0%13.0%11.7%11.4%
本期淨利(淨損)6.3%5.5%6.7%9.1%16.1%12.7%13.0%13.0%11.7%11.4%
確定福利計畫之再衡量數0.1%-0.1%0.3%0.4%0.2%0.4%0.8%-0.1%0.8%0.2%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-2.4%0.3%1.1%5.2%-2.3%0.6%1.5%1.6%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目0.0%0.0%-0.6%0.2%1.1%1.0%0.1%0.9%0.5%0.4%
不重分類至損益之項目:0.8%2.4%6.6%-1.4%1.4%2.8%2.1%
國外營運機構財務報表換算之兌換差額-1.2%-0.2%-0.3%-0.5%0.2%-0.1%0.2%-0.2%0.3%0.1%
後續可能重分類至損益之項目:-0.5%0.2%-0.1%0.2%-0.2%0.3%0.1%
其他綜合損益(淨額)-1.4%1.1%-3.0%0.3%2.6%6.5%-1.2%1.2%3.1%2.2%
本期綜合損益總額4.9%6.6%3.7%9.5%18.7%19.3%11.8%14.2%14.8%13.6%
母公司業主(淨利∕損)6.3%5.5%6.7%9.1%16.1%12.7%13.0%13.0%11.7%11.4%
母公司業主(綜合損益)4.9%6.6%3.7%9.5%18.7%19.3%11.8%14.2%14.8%13.6%
基本每股盈餘0.0%0.0%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.0%0.0%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%
銷貨退回0.8%0.8%1.1%1.6%1.0%
銷貨折讓0.2%0.0%0.0%0.2%0.0%
備供出售金融資產未實現評價損益-0.3%1.3%0.0%
採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目0.0%0.0%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。